Researchers reviewed the immune mechanisms employed by existing vaccines for invasive pneumococcal disease.
Vertex non-opioid therapy reduced pain in mid-stage trials, study shows
Vertex Pharmaceuticals has spent decades trying to develop molecules that reduce pain safely and potently, searching for success in a field its own executives have
August 2, 2023